Skip to main content

KLF4 suppresses HDACi induced caspase activation and the SAPK pathway by targeting p57Kip2

Abstract

Kruppel-like factor 4 (KLF4) belongs to a family of evolutionarily conserved zinc finger-containing transcription factors. It has been shown to mediate self renewal and pluripotency, regulate adipogenesis and play a critical role in monocyte differentiation. KLF4 is also highly expressed in squamous cell carcinomas and in 70% of all primary human breast cancers, suggesting a putative role for KLF4 as being an oncogene and as an antiapoptotic factor. However, the mechanism of this regulation remains unclear. Here, we show that KLF4 is induced during histone deacetylase inhibitor treatment, and regulates the extrinsic apoptosis pathway by inhibiting caspase cleavage. In addition, KLF4 binds to the p57Kip2 promoter and transcriptionally upregulates its expression, which in turn inhibits the stress activated protein kinase cascade and c-Jun phosphorylation. Our findings indicate that in cancer cells that express high levels of KLF4 may be refractory to HDACi treatment. Results of our study demonstrate an unexpected antiapoptotic function of KLF4, and suggest an important cell fate determinant following histone deacetylase inhibitor induced apoptosis.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

References

  1. Martinez-Iglesias O, Ruiz-Llorente L, Sanchez-Martinez R, Garcia L, Zambrano A, Aranda A (2008) Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer. Clin Transl Oncol 10:395–398

    PubMed  Article  CAS  Google Scholar 

  2. McLaughlin F, La Thangue NB (2004) Histone deacetylase inhibitors open new doors in cancer therapy. Biochem Pharmacol 68:1139–1144

    PubMed  Article  CAS  Google Scholar 

  3. Di Bernardo G, Squillaro T, Dell’aversana C, et al. (2009) Histone Deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. Stem Cells Dev 18(4):573–581

    Google Scholar 

  4. Emanuele S, Lauricella M, Tesoriere G (2008) Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). Int J Oncol 33:637–646

    PubMed  CAS  Google Scholar 

  5. La Thangue NB (2004) Histone deacetylase inhibitors and cancer therapy. J Chemother 16(Suppl 4):64–67

    PubMed  CAS  Google Scholar 

  6. Black AR, Black JD, Azizkhan-Clifford J (2001) Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143–160

    PubMed  Article  CAS  Google Scholar 

  7. Kaczynski J, Cook T, Urrutia R (2003) Sp1- and Kruppel-like transcription factors. Genome Biol 4:206

    PubMed  Article  Google Scholar 

  8. Safe S, Abdelrahim M (2005) Sp transcription factor family and its role in cancer. Eur J Cancer 41:2438–2448

    PubMed  Article  CAS  Google Scholar 

  9. Welstead GG, Brambrink T, Jaenisch R (2008) Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4. J Vis Exp (14):pii:734. doi:10.3791/734.

  10. Jiang J, Chan YS, Loh YH et al (2008) A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10:353–360

    PubMed  Article  Google Scholar 

  11. Huangfu D, Osafune K, Maehr R et al (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269–1275

    PubMed  Article  CAS  Google Scholar 

  12. Birsoy K, Chen Z, Friedman J (2008) Transcriptional regulation of adipogenesis by KLF4. Cell Metab 7:339–347

    PubMed  Article  CAS  Google Scholar 

  13. Feinberg MW, Wara AK, Cao Z et al (2007) The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J 26:4138–4148

    PubMed  Article  CAS  Google Scholar 

  14. Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW (2005) Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 15:92–96

    PubMed  Article  CAS  Google Scholar 

  15. Rowland BD, Bernards R, Peeper DS (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7:1074–1082

    PubMed  Article  CAS  Google Scholar 

  16. Foster KW, Ren S, Louro ID et al (1999) Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ 10:423–434

    PubMed  CAS  Google Scholar 

  17. Foster KW, Frost AR, McKie-Bell P et al (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res 60:6488–6495

    PubMed  CAS  Google Scholar 

  18. Foster KW, Liu Z, Nail CD et al (2005) Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24:1491–1500

    PubMed  Article  CAS  Google Scholar 

  19. Zhao Y, Hamza MS, Leong HS et al (2008) Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells. Oncogene 27:1–8

    PubMed  Article  Google Scholar 

  20. Nelson JD, Denisenko O, Bomsztyk K (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc 1:179–185

    PubMed  Article  CAS  Google Scholar 

  21. Cucciolla V, Borriello A, Criscuolo M et al (2008) Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor. Carcinogenesis 29:560–567

    PubMed  Article  CAS  Google Scholar 

  22. Chang TS, Kim MJ, Ryoo K et al (2003) p57KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein Kinase. J Biol Chem 278:48092–48098

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Academic Research Fund (AcRF), Tier 1 (RG78/07), Ministry of Education, Singapore, to ZY.

Author contributions

N.K. carried out most of the experiments; C.B.L. assisted with some experiments; M.S.H. and Z.Y. conceived and designed the project; M.S.H., N.K. and Z.Y. wrote the article. All authors participated in data analysis. All authors read and edited the article.

Conflict of interest statement

The authors declare no competing financial interests.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Mohamed Sabry Hamza or Yan Zhao.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ky, N., Lim, C.B., Li, J. et al. KLF4 suppresses HDACi induced caspase activation and the SAPK pathway by targeting p57Kip2 . Apoptosis 14, 1095–1107 (2009). https://doi.org/10.1007/s10495-009-0368-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-009-0368-0

Keywords

  • CDKN1C
  • HDAC
  • KLF4
  • Kruppel
  • SAHA
  • p57Kip2